Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Oncology Drug Applications Migrate As Part Of FDA's Reorganization Of OODP

Sep 19 2011

• By Emily Hayes

Related Content

Oncology Drug Reviews To Be Restructured As Office Shifts Away From Divisions Organized Around Molecule Size

Apr 12 2010

FDA Oncology Products Office Reorganization Keeps Leadership Intact

Jul 26 2010

Genentech Restricts Population In Last-Ditch Bid To Keep Avastin's Breast Cancer Claim

Aug 05 2011

Avastin’s Breast Cancer Approval Followed CDER Rift On Efficacy

May 30 2011

An Avastin Loophole: Hamburg Could Decide To Retain Approval During Confirmatory Trial

May 09 2011

Who's Who In The New OHOP

Sep 19 2011

<i>Avastin</i> Breast Cancer Approval Memo Comes Back To Haunt FDA’s Pazdur

Jul 18 2011

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window